573 related articles for article (PubMed ID: 14609329)
1. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence.
Guy JL; Jackson RM; Acharya KR; Sturrock ED; Hooper NM; Turner AJ
Biochemistry; 2003 Nov; 42(45):13185-92. PubMed ID: 14609329
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.
Natesh R; Schwager SL; Sturrock ED; Acharya KR
Nature; 2003 Jan; 421(6922):551-4. PubMed ID: 12540854
[TBL] [Abstract][Full Text] [Related]
3. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
Rice GI; Thomas DA; Grant PJ; Turner AJ; Hooper NM
Biochem J; 2004 Oct; 383(Pt 1):45-51. PubMed ID: 15283675
[TBL] [Abstract][Full Text] [Related]
5. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.
Donoghue M; Hsieh F; Baronas E; Godbout K; Gosselin M; Stagliano N; Donovan M; Woolf B; Robison K; Jeyaseelan R; Breitbart RE; Acton S
Circ Res; 2000 Sep; 87(5):E1-9. PubMed ID: 10969042
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action.
Skirgello OE; Balyasnikova IV; Binevski PV; Sun ZL; Baskin II; Palyulin VA; Nesterovitch AB; Albrecht RF; Kost OA; Danilov SM
Biochemistry; 2006 Apr; 45(15):4831-47. PubMed ID: 16605251
[TBL] [Abstract][Full Text] [Related]
7. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme.
Natesh R; Schwager SL; Evans HR; Sturrock ED; Acharya KR
Biochemistry; 2004 Jul; 43(27):8718-24. PubMed ID: 15236580
[TBL] [Abstract][Full Text] [Related]
8. Residues affecting the chloride regulation and substrate selectivity of the angiotensin-converting enzymes (ACE and ACE2) identified by site-directed mutagenesis.
Rushworth CA; Guy JL; Turner AJ
FEBS J; 2008 Dec; 275(23):6033-42. PubMed ID: 19021774
[TBL] [Abstract][Full Text] [Related]
9. Structure-function discrimination of the N- and C- catalytic domains of human angiotensin-converting enzyme: implications for Cl- activation and peptide hydrolysis mechanisms.
Tzakos AG; Galanis AS; Spyroulias GA; Cordopatis P; Manessi-Zoupa E; Gerothanassis IP
Protein Eng; 2003 Dec; 16(12):993-1003. PubMed ID: 14983080
[TBL] [Abstract][Full Text] [Related]
10. Peptide inhibitors and the active site(s) of angiotensin converting enzyme.
Riordan JF; Chen YN; Kleemann SG; Bünning P
Biomed Biochim Acta; 1991; 50(4-6):809-14. PubMed ID: 1666286
[TBL] [Abstract][Full Text] [Related]
11. [Angiotensin converting enzyme (kininase II). Molecular and physiological aspects].
Costerousse O; Jaspard E; Allegrini J; Wei L; Alhenc-Gelas F
C R Seances Soc Biol Fil; 1992; 186(6):586-98. PubMed ID: 1339589
[TBL] [Abstract][Full Text] [Related]
12. Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites.
Woodman ZL; Oppong SY; Cook S; Hooper NM; Schwager SL; Brandt WF; Ehlers MR; Sturrock ED
Biochem J; 2000 May; 347 Pt 3(Pt 3):711-8. PubMed ID: 10769174
[TBL] [Abstract][Full Text] [Related]
13. Structure of angiotensin I-converting enzyme.
Sturrock ED; Natesh R; van Rooyen JM; Acharya KR
Cell Mol Life Sci; 2004 Nov; 61(21):2677-86. PubMed ID: 15549168
[TBL] [Abstract][Full Text] [Related]
14. Development of domain-selective angiotensin I-converting enzyme inhibitors.
Redelinghuys P; Nchinda AT; Sturrock ED
Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685
[TBL] [Abstract][Full Text] [Related]
15. Identification of angiotensin converting enzyme 2 in the rodent retina.
Tikellis C; Johnston CI; Forbes JM; Burns WC; Thomas MC; Lew RA; Yarski M; Smith AI; Cooper ME
Curr Eye Res; 2004 Dec; 29(6):419-27. PubMed ID: 15764086
[TBL] [Abstract][Full Text] [Related]
16. Catalytic properties of recombinant dipeptidyl carboxypeptidase from Escherichia coli: a comparative study with angiotensin I-converting enzyme.
Cunha CE; Magliarelli Hde F; Paschoalin T; Nchinda AT; Lima JC; Juliano MA; Paiva PB; Sturrock ED; Travassos LR; Carmona AK
Biol Chem; 2009 Sep; 390(9):931-40. PubMed ID: 19558329
[TBL] [Abstract][Full Text] [Related]
17. Solid-phase synthesis and conformational properties of angiotensin converting enzyme catalytic-site peptides: the basis for a structural study on the enzyme-substrate interaction.
Galanis AS; Spyroulias GA; Pairas G; Manessi-Zoupa E; Cordopatis P
Biopolymers; 2004; 76(6):512-26. PubMed ID: 15508121
[TBL] [Abstract][Full Text] [Related]
18. Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis.
Guy JL; Jackson RM; Jensen HA; Hooper NM; Turner AJ
FEBS J; 2005 Jul; 272(14):3512-20. PubMed ID: 16008552
[TBL] [Abstract][Full Text] [Related]
19. Domain-selective ligand-binding modes and atomic level pharmacophore refinement in angiotensin I converting enzyme (ACE) inhibitors.
Tzakos AG; Gerothanassis IP
Chembiochem; 2005 Jun; 6(6):1089-103. PubMed ID: 15883972
[TBL] [Abstract][Full Text] [Related]
20. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
